| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 72 |
| 1 | TACROLIMUS | 57 |
| 2 | CYCLOPHOSPHAMIDE | 55 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 55 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 55 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 54 |
| 6 | TACROLIMUS OINTMENT 0.1% | 54 |
| 7 | METHOTREXATE | 53 |
| 8 | METHOTREXATE SODIUM | 53 |
| 9 | CYCLOSPORINE | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 1 | HETASTARCH | 1 | 0.0059 |
| 2 | EMAPALUMAB-LZSG | 1 | 0.0042 |
| 3 | LARONIDASE | 14 | 0.0034 |
| 4 | BUSULFAN | 31 | 0.0019 |
| 5 | FLUDARABINE PHOSPHATE | 72 | 0.0018 |
| 6 | ISRADIPINE | 1 | 0.0018 |
| 7 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 8 | VALPROATE SODIUM | 25 | 0.0012 |
| 9 | ALEMTUZUMAB | 18 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 70 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 53 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 37 |
| 3 | Corticosteroid [EPC] | 28 |
| 4 | Leukocyte Growth Factor [EPC] | 19 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 18 |
| 6 | Anti-epileptic Agent [EPC] | 17 |
| 7 | Kinase Inhibitor [EPC] | 14 |
| 8 | Complement Inhibitor [EPC] | 11 |
| 9 | Azole Antifungal [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 6 | Iron Chelator [EPC] | 9 | 0.0003 |
| 7 | Alkylating Drug [EPC] | 70 | 0.0003 |
| 8 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 37 | 0.0003 |